Summary of Product Characteristics Updated 08-Jul-2022 | Thornton & Ross Ltd
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.24 months unopened
Use within 28 days of first opening
07/07/2022
Linthwaite, Huddersfield, West Yorks, HD7 5QH
+44(0)1484 848200
+44 (0) 1484 848164